Optimizing Mental Health for Infants Exposed to Early Adversity: A Comparison of Breaking the Cycle and Maxxine Wright
Launched by UNIVERSITY OF OTTAWA · Mar 3, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two programs designed to help mothers who have faced substance use issues and their young children. The trial compares the "Breaking the Cycle" (BTC) program, which includes support for the mental health of infants, to the "Maxxine Wright" (MW) program, which mainly focuses on the mothers. Researchers want to find out if children in the BTC program show better mental health and if mothers and children in that group experience less stress and a better home environment compared to those in the MW program.
To participate in this study, mothers must be receiving services from either BTC or MW and have a child under 6 years old. They should also be able to complete a questionnaire in English. Throughout the trial, participants will fill out several questionnaires at three different times: when they start the program, one year later, and two years later. This will help researchers understand how effective these programs are and how they might improve the mental health and well-being of both mothers and their children in the long run.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • receiving services at either BTC or MW
- • having a child under the age of 6 years
- • being able to answer a questionnaire in English
- Exclusion Criteria:
- • -
About University Of Ottawa
The University of Ottawa, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials and studies. With a commitment to excellence in research and a robust network of interdisciplinary collaboration, the university leverages its expertise in various medical fields to enhance patient care and public health outcomes. The institution fosters an environment that promotes ethical research practices, ensuring the safety and well-being of participants while contributing to the scientific community's understanding of diverse health issues. Through its clinical trial initiatives, the University of Ottawa aims to translate research findings into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Surrey, British Columbia, Canada
Toronto, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials